Sticky tenants and long leases add to appeal of Life Science sector

Life science real estate is attracting growing attention from institutional investors across Europe as the sector demonstrates a resilience profile that stands in marked contrast to the battered office market — and the Netherlands is emerging as the most mature and investable market on the continent.

That was the central message from a webinar hosted by RUECKERCONSULT, in which three industry specialists made the case for a still-young asset class underpinned by structural demand, sticky tenants, and a supply deficit that shows no sign of closing. Following a slump in 2023, European transaction volume in the sector recovered to around €2.8 billion in 2024, with the key markets being the United Kingdom, Germany, France, Ireland and the Netherlands.